Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanzhou Jinglong Pharmaceutical Technology is a high-tech enterprise based in Lanzhou, China, specializing in the research, development, and production of pharmaceutical intermediates and fine chemicals. The company focuses on providing high-quality chemical building blocks and custom synthesis services to the global pharmaceutical and biotechnology industries. Their product portfolio includes a wide range of heterocyclic compounds, boronic acids, and specialized reagents used in drug discovery and development. By leveraging its expertise in organic synthesis, Lanzhou Jinglong supports early-stage research through to pilot-scale production. The company is committed to technical innovation and maintains rigorous quality control standards to meet the demands of international clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanzhou Jinglong Pharmaceutical Technology.